NewBiologix publishes paper on breakthrough HEK293 line

Published: 19-Feb-2026
Research & Development

The biotech says the newly published peer-reviewed data indicates a two-fold increase in the full-to-empty rAAV ratio using NBX1P01 compared to a leading commercial HEK293 cell line

You need to be a subscriber to read this article.
Click here to find out more.

The biotech NewBiologix has announced the publication of new peer-reviewed data supporting the use of next-generation clonal HEK293 cell line technology. 

Published in Biotechnology Reports, the paper covers the generation and characterisation of NBX1P01, the company's proprietary clonal HEK293 cell line optimised for rAAV production.

Derived from more than 2000 single-cell clones, NBX1P01 was selected for enhanced production performance and validated through extensive genomic sequencing to confirm clonality and stability.

The company states that the clonal cell line underpins rapid, effective and scalable production of viral vectors, which are central to gene therapy manufacturing.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
See more

You may also like

Research & Development

Harness Therapeutics nominates first-in-class Huntington's Disease candidate HRN001

Read more
The UK biotech has selected HRN001, an antisense oligonucleotide designed to upregulate the genetically validated FAN1 target, as its lead programme for Huntington’s disease and established a Clinical Advisory Board to support planned first-in-human studies in 2027

Trending Articles

  1. Johns Hopkins University to use Syngene's platforms to advance early-stage drug discovery The collaboration will use the CRDMO's SynVent platform and connector model to progress the university's drug discovery programmes
  2. SGS partners with theblood to advance menstrual blood-based diagnostics for women’s health Collaboration aims to establish scientific and regulatory foundations for non-invasive diagnostics targeting conditions such as endometriosis and PCOS
  3. THX Pharma and Biocodex pair up to advance rare disease research Biocodex has acquired two licences from THX Pharma to develop and commercialise Batten-1 worldwide and TX01 in the US and Canada, with the deal totalling up to $173m
  4. Extract Technology fully integrates into Dec Group and unveils new company name Dec Group UK reflects unified vision and strengthened capabilities for global customers
  5. Phase III data show AstraZeneca's Breztri significantly improves lung function in uncontrolled asthma Results published in The Lancet Respiratory Medicine demonstrate that Breztri Aerosphere delivered statistically significant lung function gains and reduced severe exacerbations in patients

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Research & Development

Harness Therapeutics nominates first-in-class Huntington's Disease candidate HRN001

The UK biotech has selected HRN001, an antisense oligonucleotide designed to upregulate the genetically validated FAN1 target, as its lead programme for Huntington’s disease and established a Clinical Advisory Board to support planned first-in-human studies in 2027
Research & Development

Phase III data show AstraZeneca's Breztri significantly improves lung function in uncontrolled asthma

Results published in The Lancet Respiratory Medicine demonstrate that Breztri Aerosphere delivered statistically significant lung function gains and reduced severe exacerbations in patients
Manufacturing

Navigating AI regulation for digital medical devices in global markets

New whitepaper outlines regulatory pathways for AI-powered medical technologies in the UK, US and EU
Research & Development

Devonian Health reports gene-level confirmation of Thykamine anti-MASH effects in preclinical liver study

STAM mouse model analysis demonstrates dose-dependent anti-inflammatory and anti-fibrotic activity of Thykamine, supporting its potential in metabolic dysfunction-associated steatohepatitis
Research & Development

SGS partners with theblood to advance menstrual blood-based diagnostics for women’s health

Collaboration aims to establish scientific and regulatory foundations for non-invasive diagnostics targeting conditions such as endometriosis and PCOS
Ingredients

Echo MS+ integration enhances high-throughput mass spectrometry

SCIEX expands compatibility with the ZenoTOF 8600 system to deliver greater sensitivity and automation capabilities
Ingredients

Lighthouse photoreactor module expands Integrity 10 platform for controlled, high-throughput photochemistry

New module enables parallel photochemistry with precise reaction control and flexible LED options
Subscribe now